跳至主要内容
临床试验/NCT07632742
NCT07632742招募中不适用

MOSES 2.0 vs Quanta Magneto 150 Holmium Laser for Holmium Laser Enucleation of the prostate-a Randomized Controlled Trial

Northwestern University1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2026年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
180
试验地点
1

研究概览

简要总结

The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.

详细描述

The Magneto 150 is a high-powered 150W holmium laser that offers similar pulse-modulation benefits of MOSES 2.0, which facilitates effective dissection and enucleation of the tissue plane while also offering a new first-of-its kind proprietary Magneto setting which allows for very low peak power of 500W and longer pulse duration which allows for better hemostasis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

Participants will be randomized to undergo HoLEP with their surgeon using the MOSES 2.0 holmium laser or the Magneto 150 holmium laser. Participants will not know their randomization prior to procedure, but they will be able to find out at any time after the HoLEP procedure.

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms
  • Internet access and a device to complete postoperative questionnaires (smartphone, tablet, laptop or desktop computer)

排除标准

  • Patients who lack decisional capacity
  • Patients unable to read/speak English
  • Patients who are on a blood thinner (anticoagulation medication)
  • Patients who do not have internet access to complete postoperative surveys

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amy Krambeck

Professor

Northwestern University

研究点 (1)

Loading locations...

相似试验